EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience

Mukpradab Darakamas iD, Sanitra Anuwutnavin iD, Fuanglada Tongprasert iD, Wisit Chankhunaphas iD, Kanyarat Nilto, Supaluck Kanjanauthai, Jarupim Soongswang

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70278 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Mukpradab Darakamas and 6 co-authors. Institution: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Tha…. Major MEDLINE topics: Flecainide, Digoxin, Anti-Arrhythmia Agents, Fetal Diseases. 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To assess the efficacy and safety of transplacental flecainide and/or digoxin for fetal tachyarrhythmias when sotalol is unavailable.

Method

We evaluated transplacental flecainide, digoxin, or combination therapy in a retrospective and prospective cohort across two Thai tertiary centers. Outcomes were classified as complete cardioversion, partial response (rate control), or treatment failure.

Results

Of 24 eligible pregnancies, 14 (58.3%) had supraventricular tachycardia (SVT), 8 (33.3%) had atrial flutter (AFL), and 2 (8.3%) had ventricular tachycardia (VT). Overall, clinical responses occurred in 91.7% (22/24) of fetuses. Flecainide monotherapy achieved 100% (9/9) complete cardioversion in SVT, compared with 50% (1/2) for digoxin. SVT combination therapy ( n = 3) yielded 1 complete and 1 partial response. Among 7 flecainide‐treated AFL cases, 5 (71.4%) achieved rate control and 2 (28.6%) achieved cardioversion; one digoxin‐treated case fully converted. Flecainide resolved 1 of 2 VT cases (50%). Response rates were unaffected by hydrops, gestational age, or cardiac defects ( p = 0.087–1.000). Maternal adverse events were mild and required no treatment discontinuation.

Conclusion

Transplacental flecainide demonstrates high efficacy in SVT and effective rate control with preserved cardiac function in AFL. Its favorable safety profile makes it a practical alternative for first‐line therapy where sotalol is unavailable and flecainide monitoring is infeasible.

Subjects

MeSH terms (MEDLINE)

FlecainideDigoxinAnti-Arrhythmia AgentsFetal DiseasesTachycardiaHumansFemalePregnancyAdultRetrospective StudiesAtrial FlutterDrug Therapy, CombinationTachycardia, SupraventricularProspective StudiesTreatment OutcomeMaternal-Fetal ExchangeYoung AdultThailand

Author keywords

atrial flutterdigoxinfetal tachyarrhythmiaflecainidesupraventricular tachycardiatransplacental therapyventricular tachycardia

Substances

FlecainideDigoxinAnti-Arrhythmia Agents

Authors and institutions

  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Fetal Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID profiles: Mukpradab Darakamas, Sanitra Anuwutnavin, Fuanglada Tongprasert, Wisit Chankhunaphas

Cite

APA

Darakamas, M., Anuwutnavin, S., Tongprasert, F., Chankhunaphas, W., Nilto, K., Kanjanauthai, S., & Soongswang, J. (2026). Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience. Prenatal Diagnosis. https://doi.org/10.1002/pd.70278

Vancouver

Darakamas M, Anuwutnavin S, Tongprasert F, Chankhunaphas W, Nilto K, Kanjanauthai S, et al. Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience. Prenatal Diagnosis. 2026. doi:10.1002/pd.70278

BibTeX
@article{Darakamas2026,
  author = {Darakamas, Mukpradab and Anuwutnavin, Sanitra and Tongprasert, Fuanglada and Chankhunaphas, Wisit and Nilto, Kanyarat and Kanjanauthai, Supaluck and Soongswang, Jarupim},
  title = {Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70278}
}
Start for free →